510(k) K193155
K193155 is an FDA 510(k) premarket notification submitted by Nipro Renal Solutions USA, Corp. for the device "Nipro Dry Complete Dry Acid Concentrate for Hemodialysis". The FDA issued a decision of Substantially Equivalent on Nov 25, 2020. The device falls under product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)), a Class II device regulated under 21 CFR 876.5820. Nipro Renal Solutions USA, Corp. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 25, 2020
- Date Received
- Nov 14, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Device Class
- Class II
- Regulation Number
- 876.5820
- Review Panel
- GU
- Submission Type
- 510(k)
Need the full FDA record for Nipro Renal Solutions USA, Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.